Frontlight ResearchEarly access
TerminatedNo phase
Safety and Efficacy of Remote Ischemic Conditioning in Patients With Severe Stenosis or Occlusion of Anterior Intracranial Circulation Vessels
Key facts
- Who runs it
- The First Affiliated Hospital of University of Science and Technology of China
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 458 people enrolled
- Started
- 5 Apr 2025
- Ended
- 28 Feb 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- RIC
- Sham
- Guideline-based therapy
- Record updated
- 10 June 2026
- Why it stopped
- The reason for the early termination is that the results of the mediation analysis are inconclusive.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Age is 18 years old or above
- Severe stenosis (70% - 99%) or occlusion of anterior intracranial circulation vessels, mainly including the intracranial segment of the internal carotid artery, middle cerebral artery (M1, M2) and anterior cerebral artery (A1, A2), which is confirmed by digital subtraction angiography (DSA), computed tomography angiography (CTA) or magnetic resonance angiography (MRA)
- Patients with clinically diagnosed acute ischemic stroke who received remote ischemic treatment within 72 hours after the onset
- The NIHSS score ranges from 4 to 24
- The mRS score before stroke is less than or equal to 1
- informed consent
Who cannot take part
- Systolic blood pressure > 185 mmHg or diastolic blood pressure > 110 mmHg, and uncontrollable by antihypertensive drugs
- Patients who participated in other clinical trials within 3 months before enrollment or are currently participating in other clinical trials
- Patients who have previously received remote ischemic treatment or similar treatments
- Cerebral venous thrombosis or stenosis
- Patients with any serious diseases and a life expectancy of less than 1 year
- Patients with vessel recanalization after mechanical thrombectomy (TICI grade ≥ 2b)
- Patients planning to receive intracranial endovascular treatment within 3 months
- Patients diagnosed with acute posterior circulation cerebral infarction
- Symptoms caused by non - culprit vessels
- Ipsilateral extracranial vessel stenosis ≥ 70%
- Intracranial tumors, arteriovenous malformations or aneurysms
- Severe coagulation abnormalities
- Any contraindications to remote ischemic conditioning: severe soft tissue injury, fracture or vascular injury of the upper limb, perivascular lesions of the distal upper limb, etc
- Patients who cannot be followed up (such as those without a fixed residence, overseas patients, etc.)
- Pregnant or lactating women
- Patients whom the researchers consider unsuitable for this clinical study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The primary purpose of this study is to examine whether remote ischemic treatment can better the 90 - day neurological outcomes in acute ischemic stroke patients having severe stenosis or occlusion of anterior intracranial circulation vessels.
The 2 groups in the trial
- RIC group+Guideline-based therapyTreatment being tested
RIC is given twice a day with 200mmHg pressure.
Treatment: RIC and Guideline-based therapy
- Sham group+Guideline-based therapyExisting treatment, for comparison
RIC is given twice a day with 60mmHg pressure.
Treatment: Sham and Guideline-based therapy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 10 June 2026